The contract research organization and technology solution is for the execution of ophthalmology clinical trials.
The FDA and Palatin agreed on a clear regulatory path for PL9643 NDA submission in DED. The company hopes to start patient ...
Investigators at the Dean McGee Eye Institute reviewed the accuracy of the tools in measuring 5 vision assessment parameters, ...
MK-3000, formally known as EYE103, is an investigational, potentially first-in-class tetravalent, tri-specific antibody that ...
Ocuphire Pharma announced it has dosed the first patient in its VEGA-3, phase 3 clinical trial ( NCT06542497) of phentolamine ...
Life, is a highly specific antibody fragment, possibly enabling an optimized penetration through all retinal layers to the ...
A team of researchers at the Center for Regenerative Therapies Dresden of Dresden University of Technology is working to ...
BVI, a global ophthalmic device company, announced its SERENITY and SERENITY Toric premium monofocal IOLs will launch at the ...
Andrew Lee, MD, and Andrew Carey, MD, sit down on another episode of the NeuroOp Guru to discuss Multiple Sclerosis and its ...
The US Food and Drug Administration has granted an Orphan Drug Designation (ODD) for SKG1108 from Skyline Therapeutics for ...
Clearside Biomedical has completed the final participant visit in the ODYSSEY Phase 2b clinical trial of CLS-AX (axitinib injectable suspension) in neovascular age-related macular degeneration (wet ...
In the case study, a 63-year-old patient presented with severe acute pain in the right eye, which was diagnosed as a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback